Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Jul 26, 2023
Wednesday Jul 26, 2023
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three leading experts provide their insights on detection methods for HER2 amplification, as well as the clinical efficacy data for guideline-recommended HER2-targeted therapies and emerging HER2-targeted therapies for patients with metastatic colorectal cancer.
The experts
- Dr Andrew Wotherspoon - Royal Marsden Hospital, London, UK;
- Dr Andrea Cercek - Memorial Sloan Kettering Cancer Center, New York, NY, USA;
- Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain;
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical educational grant from Seagen Inc., and is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncologyime.org/fulfilling_the_potential_of_her2_targeting_in_crc/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.